» Articles » PMID: 17607512

Physical and Biocompatibility Studies of Novel Titanium Dioxide Doped Phosphate-based Glasses for Bone Tissue Engineering Applications

Overview
Publisher Springer
Date 2007 Jul 4
PMID 17607512
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

This study investigated doping titanium dioxide (TiO(2)) into phosphate glasses, 50 P(2)O(5)-30 CaO-20 Na(2)O, to control their degradation rate and enhance their biological response to be suitable scaffolds for bone tissue engineering applications. The thermal and structural properties were analysed using differential thermal analysis and X-ray powder diffraction. The effect of TiO(2) incorporation on degradation rate, ion release, and pH changes was also carried out. In vitro cyto-biocompatibility was assessed through MG63 human osteosarcoma cells attachment and viability using scanning electron microscopy and confocal microscopy, respectively. The results showed that addition of TiO(2) produced a significant increase in density and glass transition temperature. X-ray diffraction analysis showed the presence of NaCa(PO(3))(3) as a main phase of these glasses with titanium phosphate Ti-P(2)O(7) only detected for 5 mol% TiO(2) glasses. The degradation rate, however, was significantly reduced by one order of magnitude with incorporation of 5 mol% TiO(2) which has been reflected in released ions (cations and anions) and the minimal pH changes. Moreover, addition of TiO(2), 3 and 5 mol% in particular, supported the MG63 cells attachment and maintained high cell viability up to 7 days culture comparable to Thermanox. These results suggested that TiO(2) containing phosphate glasses can be a promising substrate for bone tissue engineering applications.

Citing Articles

Biological Evaluation of Zinc Phosphate Cement for Potential Bone Contact Applications.

Kotha A, Nicholson J, Booth S Biomedicines. 2023; 11(2).

PMID: 36830786 PMC: 9953316. DOI: 10.3390/biomedicines11020250.


Recent advances and future perspectives of sol-gel derived porous bioactive glasses: a review.

Deshmukh K, Kovarik T, Krenek T, Docheva D, Stich T, Pola J RSC Adv. 2022; 10(56):33782-33835.

PMID: 35519068 PMC: 9056785. DOI: 10.1039/d0ra04287k.


Development of titanium dioxide nanowire incorporated poly(vinylidene fluoride-trifluoroethylene) scaffolds for bone tissue engineering applications.

Augustine A, Augustine R, Hasan A, Raghuveeran V, Rouxel D, Kalarikkal N J Mater Sci Mater Med. 2019; 30(8):96.

PMID: 31414231 PMC: 6694083. DOI: 10.1007/s10856-019-6300-4.


Assessing behaviour of osteoblastic cells in dynamic culture conditions using titanium-doped phosphate glass microcarriers.

Thompson D, Peticone C, Burova I, Shipley R, Knowles J, Kim H J Tissue Eng. 2019; 10:2041731419825772.

PMID: 30800261 PMC: 6378638. DOI: 10.1177/2041731419825772.


Bioactivation of titanium dioxide scaffolds by ALP-functionalization.

Sengottuvelan A, Balasubramanian P, Will J, Boccaccini A Bioact Mater. 2018; 2(2):108-115.

PMID: 29744418 PMC: 5935041. DOI: 10.1016/j.bioactmat.2017.02.004.


References
1.
Ahmed I, Collins C, Lewis M, Olsen I, Knowles J . Processing, characterisation and biocompatibility of iron-phosphate glass fibres for tissue engineering. Biomaterials. 2004; 25(16):3223-32. DOI: 10.1016/j.biomaterials.2003.10.013. View

2.
Walgenbach K, Voigt M, Riabikhin A, Andree C, Schaefer D, Galla T . Tissue engineering in plastic reconstructive surgery. Anat Rec. 2001; 263(4):372-8. DOI: 10.1002/ar.1117. View

3.
Navarro M, Del Valle S, Martinez S, Zeppetelli S, Ambrosio L, Planell J . New macroporous calcium phosphate glass ceramic for guided bone regeneration. Biomaterials. 2004; 25(18):4233-41. DOI: 10.1016/j.biomaterials.2003.11.012. View

4.
Lee S, Choi J, Suk Park K, Khang G, Lee Y, Lee H . Response of MG63 osteoblast-like cells onto polycarbonate membrane surfaces with different micropore sizes. Biomaterials. 2004; 25(19):4699-707. DOI: 10.1016/j.biomaterials.2003.11.034. View

5.
Tseng L, Huang C, Hsu S, Chen J, Cheng H, Chang H . Effect of calmidazolium on Ca(+2) movement and proliferation in human osteosarcoma cells. Clin Exp Pharmacol Physiol. 2004; 31(10):732-7. DOI: 10.1111/j.1440-1681.2004.04087.x. View